Scipher Medicine
  • Contact
  • Platform
  • Solutions
  • Company
  • Latest
  • Careers
  • Contact
  • Join Us

All articles

    All articles Press Releases Publications News Articles Media Kit
    Show all Press Releases Publications News Articles Media Kit
  • 4/28/22
    Press releases
    Scipher Medicine Publishes New Data Further Supporting Clinical Utility of PrismRA Blood Test
  • Pill packs 3/29/22
    Publications
    Budget Impact and Clinical Outcomes of a Molecular Signature to Inform TNFi Treatment Selection in Commercial Patients with Rheumatoid Arthritis 
  • Human Interactome Network 3/16/22
    Publications
    Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis
  • Headshot of Chief Technology Officer Slava Akmaev 2/28/22
    Press releases
    Scipher Medicine to Participate in Truist Securities Life Sciences AI Symposium
  • scipher medicine slash on purple background 2/24/22
    Press releases
    Scipher Medicine Closes $110 Million Financing
  • John Strumbos 2/11/22
    Press releases
    Scipher Medicine to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
  • Sam Asgarian 2/1/22
    Press releases
    Scipher Medicine Announces Publication of Real-World Study Demonstrating Clinical Utility of PrismRA Blood Test
  • 1/6/22
    Press releases
    Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference
  • Developing New Drug Treatments 12/30/21
    Publications
    Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis
  • Richard Blackburn 12/16/21
    Press releases
    Scipher Medicine Appoints Richard Blackburn to its Advisory Board
  • PrismRA test box 12/6/21
    Press releases
    Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA Blood Test Since Its Launch A Year Ago
  • Michael Elliott 12/2/21
    Press releases
    Scipher Medicine  Appoints Dr. Michael Elliott to its Science Advisory Board
  • Human Interactome Network 12/1/21
    Publications
    Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
  • PrismRA test box 11/30/21
    Press releases, News articles
    America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
  • Sam Asgarian 11/16/21
    Press releases
    Scipher Medicine® Appoints Sam Asgarian, M.D., MBA, Chief Medical Officer

Posts navigation

1 2 … 7 Next
Scipher Medicine
  • Privacy Policy
  • Patient Opt-out Information
  • Notice of Privacy Practices
  • Terms of Use
  • Cookies Acknowledgement
  • Site Map
©2022 Scipher Medicine. All rights reserved.
    • Platform
    • Solutions
    • Company
    • Latest
    • Careers
    • Contact
    • Join Us